ABSTRACT
INTRODUCTION Dressings are medical devices used to treat wounds and are subject to manufacturing and security requirements almost identical to those of drugs. The deciding authorities (mainly the Food and Drug Administration) recommend conducting randomized controlled clinical trials for registration under the “brand names” for the new dressings that do not fi t into the “generic” class. These are largely used since the 1980s for some of the generic medicines (1).
